No Data
No Data
No Data
No Data
No Data
The Price Is Right For Glaukos Corporation (NYSE:GKOS)
When close to half the companies in the Medical Equipment industry in the United States have price-to-sales ratios (or "P/S") below 3.1x, you may consider Glaukos Corporation (NYSE:GKOS) as a stock to
Simply Wall StApr 18 07:24 ET
Glaukos Announces the Release of Its 2023 Sustainability Report
Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has
BusinesswireApr 16 16:05 ET
Express News | Glaukos Corp : Truist Securities Raises Target Price to $120 From $110
Moomoo 24/7Apr 15 04:25 ET
Needham Sees BSX, CNMD, RMD Beating Street, Despite Medtech Slow Down
Seeking AlphaApr 14 17:56 ET
Glaukos (GKOS) Gains Nearly 25% YTD: What's Driving the Rally?
Yahoo FinanceApr 12 09:22 ET
Is Now The Time To Look At Buying Glaukos Corporation (NYSE:GKOS)?
Yahoo FinanceApr 11 10:47 ET
Joy Boy Myth :
thank you Meltyy, I think you forgot to mention $Fortress Biotech (FBIO.US)$ $Fortress Biotech Inc Series A P (FBIOP.US)$
it's still has relation with $Checkpoint Therapeutics (CKPT.US)$
here the picture
Joy Boy Myth : saved
No Data
No Data